B. Riley Wealth Advisors’s Calumet Specialty Products CLMT Stock Holding History

B. Riley Wealth Advisors’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,333	Closed	-$30	–	809
2014 Q4	$30	Buy	+1,333	New	+$34.7K	﹤0.01%	2349
2014 Q3	–	Sell	-1,488	Closed	-$47.3K	–	855
2014 Q2	$47.3K	Buy	+1,488	New	+$44.3K	0.01%	1054

Other funds holding CLMT

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SOAMC

Spirit of America Management Corp Syosset, New York $530M AUM 36.47% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCA

Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

B. Riley Wealth Advisors's CLMT Position: Q1 2015 in Review

B. Riley Wealth Advisors sold out of Calumet Specialty Products (CLMT) in Q1 2015, closing a stake of 1,333 shares — an estimated $30 sold.

B. Riley Wealth Advisors first reported a position in CLMT in Q2 2014 and held it in 2 quarters. The position peaked at $47.3K in Q2 2014. 117 funds tracked by Wall St. Rank hold CLMT as of Q1 2015.

B. Riley Wealth Advisors reported no remaining Calumet Specialty Products position as of Q1 2015 after selling out during the quarter.
B. Riley Wealth Advisors sold 1,333 Calumet Specialty Products shares in Q1 2015, an estimated $30.
B. Riley Wealth Advisors first reported a position in Calumet Specialty Products in Q2 2014 and held it in 2 quarters.
B. Riley Wealth Advisors's Calumet Specialty Products position peaked at $47.3K in Q2 2014.
117 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2015.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2015, filed 14 May 2015.